✦ LIBER ✦

Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer

✍ Scribed by Gajria, D.; Seidman, A.D.

Book ID: 122087540
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 101 KB
Volume: 20
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(09)79316-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship between effects on time-to-

Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer

✍ Sherrill, B; Amonkar, M; Wu, Y; Hirst, C; Stein, S; Walker, M; Cuzick, J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 151 KB

PCN3 CORRELATION BETWEEN TIME TO PROGRES

PCN3 CORRELATION BETWEEN TIME TO PROGRESSION AND OVERALL SURVIVAL IN PATIENTS WITH METASTATIC BREAST CANCER

✍ B Sherrill; C Hirst; Y Wu; MM Amonkar; S Stein 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

P143 Retrospective pooled analysis to as

P143 Retrospective pooled analysis to assess correlation between time to progression and overall survival in patients with breast cancer

✍ B. Sherrill; C. Hirst; Y. Wu; M. Amonkar; S.H. Stein 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Relationship of Circulating Tumor Cells

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

✍ Cohen, S. J.; Punt, C. J.A.; Iannotti, N.; Saidman, B. H.; Sabbath, K. D.; Gabra 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 203 KB

Surrogacy of tumor response and progress

Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes

✍ Yoshihiro Matsubara; Satomi Sakabayashi; Tsutomu Nishimura; Takanori Ishida; Nor 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 288 KB

7124 Association between time to disease

7124 Association between time to disease progression (TDP) endpoints and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)

✍ Delea, T.; Khuu, A.; Kay, A.; Zheng, J.; Baladi, J.F. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB